Hospira Recalls Marcaine Injection Due to Metal Particles
Hospira recalls 40,360 vials of Marcaine injection due to visible metal particles. Check lot 25-220-DD and expiration date Jan 1, 2015.
Stop using this now
Presence of Particulate Matter: Units of this lot may have visible metal particles embedded in the vial and in the solution causing the product to be discolored.
Contact the company
What happened, in plain English
Hospira Inc. is recalling specific lots of Marcaine (bupivacaine HCl) injection because the vials may contain visible metal particles. These particles can cause the solution to be discolored and pose a risk if injected into patients. The recall affects 40,360 single-dose vials distributed nationwide. Read more at govinfonow.com/recall/46550-hospira-inc-recalls-marcaine-bupivacaine-hcl-injection-usp-0-25.
Source Summary by GovInfoNow · govinfonow.com/recall/46550-hospira-inc-recalls-marcaine-bupivacaine-hcl-injection-usp-0-25 · Updated October 13, 2026 · FDA enforcement record: FDA #D-1161-2014
Cite this page
“Hospira Recalls Marcaine Injection Due to Metal Particles.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46550-hospira-inc-recalls-marcaine-bupivacaine-hcl-injection-usp-0-25. Based on FDA recall #D-1161-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1161-2014%22&limit=1).
Why it’s dangerous
The presence of embedded metal particles in the vial and solution creates a physical hazard. If injected, these particles could cause serious injury or adverse reactions in patients.
Who’s affected
Healthcare providers and facilities that stock or administer Marcaine injection are affected. Patients who may have received this specific lot of medication are at risk for exposure to foreign particulate matter.
How to tell if you have this one
Check for Marcaine (bupivacaine HCl) injection, USP, 0.25%, 30 mL single-dose vials packaged in 10-count cartons. Look for NDC 0409-1559-30 and Lot number 25-220-DD with an expiration date of 1JAN2015.
- Brand
Hospira- Category
Drug
What to do — step by step
Identify Affected Inventory
Check stock for Marcaine injection vials with NDC 0409-1559-30 and Lot 25-220-DD expiring on 1JAN2015.
Stop Using the Product
Do not administer these vials to patients due to the risk of metal particles.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.2 years after the firm started it.
- Firm started the recall
- FDA classified it Class I
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
What is the NDC number for the recalled product?
The National Drug Code (NDC) is 0409-1559-30.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1161-2014 (October 18, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1161-2014 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.